載入...
An overview of some potential immunotherapeutic options against COVID-19
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despite relentless efforts to control the disease by drug repurposing, there is...
Na minha lista:
| 發表在: | Int Immunopharmacol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7908848/ https://ncbi.nlm.nih.gov/pubmed/33765610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107516 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|